Trial site
Kliniczny Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej w Rzeszowie
Rzeszów, 35-301, PolandEU-13 widening countryNot linked to an institution yet
- 20running trials
- 5closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Phase
- Phase 316 trials
- Phase 24 trials
- Phase 2/32 trials
- Phase 42 trials
- Status
- Active, not recruiting10 trials
- Recruiting7 trials
- Completed5 trials
- Not yet recruiting3 trials
- Suspended2 trials
- Lead sponsor
- Novo Nordisk A/S5 trials
- Eli Lilly and Company2 trials
- GPOH gGmbH2 trials
- Medical University Of Gdansk2 trials
- AstraZeneca1 trial
- and 15 more
Running trials
Recruiting
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
NCT07817875· Phase 3· Eli Lilly and Company· Source
Contact: Artur Mazur (principal investigator)
Recruiting
Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
NCT07220252· Phase 2/3· TG Therapeutics, Inc.· Source
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
NCT07253285· Phase 3· Novo Nordisk A/S· Source
Recruiting
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
2024-514635-26-00· Phase 3· Medical University Of Gdansk· Source
Recruiting
CRF2 Agonist for the Treatment of Worsening Heart Failure
NCT06815471· Phase 2· Corteria Pharmaceuticals· Source
Recruiting
Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway.
2024-518316-39-00· Phase 2/3· Medical University Of Lodz· Source
Recruiting
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
NCT06672549· Phase 3· Eli Lilly and Company· Source
Contact: Artur Mazur (principal investigator)
Recruiting
EXtensive mulTilayer stEnt treatmeNt in Aortic disSectiOn
NCT06675617· Intressa Vascular SA· Source
Contact: Virginie Martin
Active, not recruiting
STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
NCT06571383· Phase 4· Novo Nordisk A/S· Source
Active, not recruiting
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06029972· Phase 2· Gilead Sciences· Source
Recruiting
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
NCT05665608· Charite University, Berlin, Germany· Source
Contact: Gerhard Hindricks, Prof
Active, not recruiting
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
NCT05639114· Phase 3· Novartis Pharmaceuticals· Source
Active, not recruiting
A Research Study Looking at How Safe Somapacitan is and How Well it Works in Children Who Need Help to Grow - REAL 9
NCT05723835· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325· Phase 3· Novo Nordisk A/S· Source
Active, not recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
NCT05138133· Phase 3· AstraZeneca· Source
Recruiting
A multicentre study evaluating the safety of reperfusion thrombolytic therapy with intravenous recombinant tissue plasminogen activator (rtPA) for ischaemic stroke in patients on the non-vitamin K antagonist oral anticoagulant after reversing anticoagulant activity with a specific antidote.
2024-518509-17-00· Phase 2· Medical University Of Gdansk· Source
Active, not recruiting
AIEOP-BFM 2017 POLAND - Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia -
A randomized phase III study conducted in agreement with the AIEOP-BFM study group
2024-517253-27-00· Phase 3· Medical University Of Silesia Katowice Poland· Source
Active, not recruiting
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Participants With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study)
NCT04806451· Phase 3· Neurocrine Biosciences· Source
Recruiting
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
NCT04043494· Phase 3· University Hospital Muenster· Source
Active, not recruiting
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
NCT03007147· Phase 3· Children's Oncology Group· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error